A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection

American Journal of Gastroenterology

Volumn 94, Issue 11, 1999, Pages 3170-3174

  Sharma, Virender K ^a   Vasudeva, Rajeev ^a   Howden, Colin W ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; CARBON 13; CARBON 14; CLARITHROMYCIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TETRACYCLINE; UREA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BREATH ANALYSIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MEDICAL PRACTICE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SERODIAGNOSIS; SYMPTOM; UNITED STATES;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ATTITUDE OF HEALTH PERSONNEL; BREATH TESTS; CARBON ISOTOPES; CARBON RADIOISOTOPES; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; ENZYME INHIBITORS; GASTROENTEROLOGY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; PENICILLINS; PHYSICIAN'S PRACTICE PATTERNS; PROTON PUMPS; QUESTIONNAIRES; RADIOPHARMACEUTICALS; UREA;

EID: 0032749997     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00571-7     Document Type: Article

References (25)

1. Howden C.W., Hunt R.H. Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol. 93:1998;2330-2338.
2. Peura D.A. The report of the Digestive Health Initiative International Update Conference on Helicobacter pylori. Gastroenterology. 113:(suppl 1):1997;S4-S8.
3. Howden C.W. For what conditions are there evidence-based justification for treatment of Helicobacter pylori infection? Gastroenterology. 113:(suppl 1):1997;S107-S112.
4. Kuipers E.J., Lundell L., Klinkenberg-Knol E.C., et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 334:1996;1018-1022.
5. Lundell L., Havu N., Andersson A., et al. Gastritis development and acid suppression therapy revisited Results of a randomized study with long-term follow-up . Gastroenterology. 112:1997;A28. (abstract).
6. Lee J.M., O'Morain C.A. Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease? Gut. 43:(suppl 1):1998;S14-S20.
7. Richter J.E., Falk G.W., Vaezi M.F. Helicobacter pylori and gastroesophageal reflux disease The bug may not be all bad . Am J Gastroenterol. 93:1998;1800-1802.
8. Labenz J., Blum A.L., Bayerdorffer E., et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 112:1997;1442-1447.
9. Vicari J.W., Peek R.M., Falk G.W., et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 115:1998;50-57.
10. Wu J.C.Y., Leung W.K., Chan F.K.L., et al. H. pylori infection protects GERD patients against severe esophagitis. Gut. 43:(suppl 2):1998;A112. (abstract).
11. Warburton V.J., McNulty C.A.M., Shepherd N., et al. The importance of cagA + Helicobacter pylori to the development of oesophageal disease. Gut. 43:(suppl 2):1998;A14. (abstract).
12. Asaka M., Takeda H., Sugiyama T., et al. What role does Helicobacter pylori play in gastric cancer? Gastroenterology. 113:(suppl 1):1997;S56-S60.
13. Uemura N., Mukai T., Okamoto S., et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomark Prevent. 6:1997;639-642.
14. Thiede C., Morgner A., Alpen B., et al. What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma? Gastroenterology. 113:(suppl 1):1997;S61-S64.
15. Leontiadis G.I., Sharma V.K., Howden C.W. Non-gastrointestinal associations of Helicobacter pylori infection What is the evidence? Arch Intern Med. 159:1999;925-940.
16. Rebora A., Drago F., Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol. 89:1994;1603-1604. (letter).
17. Parish L.C., Witkowski J.A. Acne rosacea and Helicobacter pylori betrothed. Int J Dermatol. 34:1995;236-237.
18. Kolibasova K., Tothova I., Baumgartner J., et al. Eradication of Helicobacter pylori as the only successful treatment in rosacea. Arch Dermatol. 132:1996;1393-1394.
19. Powell F.C., Dawa M.A., Duguid C. Positive Helicobacter pylori serology in rosacea patients. Irish J Med Sci. 161S:1992;75. (abstract).
20. Sharma V.K., Lynn A., Kaminski M., et al. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol. 93:1998;220-222.
21. Huang J.-Q., Chiba N., Wilkinson J.M., et al. Which combination therapy can eradicate >90% Helicobacter pylori (H. pylori) infection? A meta-analysis of amoxicillin, metronidazole, tetracycline and clarithromycin-containing regimens. Gastroenterology. 112:1997;A19. (abstract).
22. Weissfeld A.S., Simmons D.E., Vance P.H., et al. In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from two multi-center United States clinical trials. Gastroenterology. 110:1996;A295. (abstract).
23. Dore M.P., Realdi G., Mura I., et al. Amoxicillin-resistant strains of H. pylori undergo reversible loss of resistance after storage. Gut. 41:(suppl 1):1997;A8. (abstract).
24. Schwartz H., Krause R., Sahba B., et al. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence A randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and amoxicillin in different dosage regimens . Am J Gastroenterol. 93:1998;584-590.
25. Vakil N., Hahn B., McSorley D. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am J Gastroenterol. 93:1998;1432-1435.